Frontiers in Microbiology

OCT 23, 2026 · JOURNAL ARTICLE

Medicinal plant-derived bioactive compounds modulate gut microbiota–host signaling in cancer-related fatigue: a phenotype-to-target framework

Frontiers in Microbiology

Cancer-related fatigue (CRF) is a frequent and disabling symptom during cancer and anticancer therapy, and pathway-directed pharmacological treatment remains limited. This review e

OCT 21, 2026 · JOURNAL ARTICLE

Unlocking oncolytic virotherapy potential: leveraging bacteriophages to conquer immunosuppression

Frontiers in Microbiology

Oncolytic virotherapy (OVT) offers great potential as an immunotherapy by lysing cancer cells and inducing immunogenic cell death, inciting an anti-tumor immune response. However,

OCT 20, 2026 · JOURNAL ARTICLE

Illuminating the microbial ‘dark matter’ in obesity: integrated multi-omics approaches to characterize uncultured taxa and their potential metabolic crosstalk with host pathways

Frontiers in Microbiology

Background Obesity is a global health challenge shaped by interactions among host genetics, diet, lifestyle, and gut microbial ecology. Although reference genome catalogues and cul

OCT 19, 2026 · JOURNAL ARTICLE

Point-of-care testing in the diagnosis of infectious diseases

Frontiers in Microbiology

Point-of-care testing (POCT) has emerged as an indispensable diagnostic strategy for addressing the increasing global burden of infectious diseases and the worsening threat of anti

OCT 13, 2026 · JOURNAL ARTICLE

Gut microbiome taxonomic and functional capacity alterations in CHD and HFpEF

Frontiers in Microbiology

The gut microbiome is known to modulate metabolic health, yet its role in coronary heart disease (CHD) and heart failure with preserved ejection fraction (HFpEF) remains unclear. I

OCT 13, 2026 · JOURNAL ARTICLE

Evaluating traditional Chinese medicine modulation of the gut microbiota–bile acid axis in metabolic and inflammatory diseases: mechanistic evidence and translational priorities

Frontiers in Microbiology

Metabolic dysfunction-associated steatotic liver disease (MASLD), obesity, type 2 diabetes mellitus (T2D), and inflammatory bowel disease (IBD) are clinically distinct disorders th

OCT 12, 2026 · JOURNAL ARTICLE

Geographical migration and fitness dynamics of Streptococcus pneumoniae: a perspective from contrasting selective pressures

Frontiers in Microbiology

Streptococcus pneumoniae remains a leading cause of pneumonia, meningitis, and sepsis worldwide, imposing a substantial burden on global public health (Cliff et al., 2024, Mahtab e

OCT 9, 2026 · JOURNAL ARTICLE

Diverse Staphylococcus aureus lineages in a tertiary hospital in North Central Nigeria: emergence of CC1-ST772-MRSA, CC8-ST789-MRSA, and ST152-MRSA

Frontiers in Microbiology

Introduction Staphylococcus aureus is a human pathogen associated with both hospital- and community-acquired infections. Data on its molecular epidemiology in North Central Nigeria